Tag Archives: Therapy

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

Making radiation therapy less toxic to the heart

SPOKANE, Wash. – Panshak Dakup, a WSU Spokane graduate student, received a Pre‑doctoral Fellowship from the American Heart Association. The two‑year fellowship comes with $ 53,688 to support his research, which he is conducting in the laboratory of Shobhan Gaddameedhi at the WSU College of Pharmacy and Pharmaceutical Sciences (CPPS). “We are interested in pursuing this study because heart failure… Read More »

High-cost Gilead cell therapy proves durable for some lymphoma patients

SAN DIEGO (Reuters) – Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta were still responding to the cell therapy after at least two years of follow-up, the company said on Sunday. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1,… Read More »